DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

55.13 1.08 (2.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $55.13 2.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.57
Previous Close $54.05
Daily Range $54.32 - $55.28
52-Week Range $44.62 - $61.33
Market Cap $159.0B
P/E Ratio 28.45
Dividend (Yield) $1.76 (3.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 16,564,378
Average Daily Volume 10,671,636
Current FY EPS $3.48





Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary

This Drug Could Outsell Medical Marijuana

Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.

Gilead Sciences: Pricing, Politics And Profits

Market Reaction To Johnson & Johnson's Earnings Is Justified

Roche’s Cancer Drug Sales Continue To Grow, May Face Competition In Medium Term

Gilead Sciences: Clear The Dockets And Settle With Merck Already

Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog

PetMed’s results hurt by shortened flea and tick season — seriously?

3 Stocks Reiterated As A Buy: INTC, MRK, JNJ

Dow Jones (DJIA) Today: Merck (MRK) Higher

Interesting April 2015 Stock Options for MRK

US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigati

US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigational Pediatric Hexavalent Vaccine

See More MRK News...

MRK's Top Competitors

MRK $55.13 (2.00%)
Current stock: MRK
JNJ $100.36 (1.17%)
Current stock: JNJ
RHHBY $36.39 (1.51%)
Current stock: RHHBY
PFE $28.28 (1.25%)
Current stock: PFE